1Y Annualised Return
▼-8.08%
3Y Annualised Return
▲4.87%
5Y Annualised Return
▲39.56%
Parnax Lab SIP Return Calculator
Over the past
1 year
3 years
5 years
Total Investment of ₹65,00,000
Would have become ₹62,43,323 (-3.95%)
Daily SIP of ₹25,000 would have become ₹62,43,323 in 1 year with a gain of ₹-2,56,676 (-3.95%)
Parnax Lab Stock Performance
Today’s Low - High
100.80
100.95
100.80
100.95
52 Week Low - High
81.00
193.50
81.00
193.50
Open
100.95
Prev. Close
100.95
Volume
20.00
Total Traded Value
2016.00
Parnax Lab Fundamental
Market Cap (in crs)
115.95
Face Value
10
Turnover (in lacs)
0.02
Key Metrics
Qtr Change %
47.91% Fall from 52W High
9.7
Dividend yield 1yr %
0
Parnax Lab Key Financials
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
Parnax Lab Quarterly Revenue
| Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|
49.04 Cr | 40.22 Cr | 48.36 Cr | 50.12 Cr | 46.37 Cr |
Parnax Lab Yearly Revenue
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
189.41 Cr | 189.53 Cr | 168.38 Cr | 163.36 Cr | 90.27 Cr | 95.98 Cr |
Parnax Lab Quarterly Net Profit/Loss
| Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|
2.93 Cr | 1.21 Cr | 3.41 Cr | 3.99 Cr | 2.25 Cr |
Parnax Lab Yearly Net Profit/Loss
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
11.54 Cr | 9.62 Cr | 8.63 Cr | 8.26 Cr | -0.36 Cr | -2.92 Cr |
Parnax Lab Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
100.8
Current Price
5Day EMA
103.60
10Day EMA
104.70
12Day EMA
104.70
20Day EMA
104.00
26Day EMA
103.40
50Day EMA
103.20
100Day EMA
108.80
200Day EMA
114.70
5Day SMA
104.30
10Day SMA
106.00
20Day SMA
104.60
30Day SMA
101.60
50Day SMA
100.40
100Day SMA
105.60
150Day SMA
124.90
200Day SMA
126.90
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 844 Rs | 844 Rs |
Week Rs | 1716 Rs | 1716 Rs |
Month Rs | 5177 Rs | 5177 Rs |
Resistance & Support
101.50
Pivot
Resistance
First Resistance
102.05
Second Resistance
103.15
Third Resistance
103.70
Support
First Support
100.40
Second support
99.85
Third Support
98.75
Relative Strength Index
45.63
Money Flow Index
72.79
MACD
1.36
MACD Signal
2.21
Average True Range
3.27
Average Directional Index
19.69
Rate of Change (21)
4.07
Rate of Change (125)
-37.30
Similar stocks
Similar Stocks
Peer comparison
Compare
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
- | 111.33 | 105 | 269.75 | 172.95 | -3.92% | 6.56% | -17.64% | 59.56% | 105.53% | 0.00% | 38.35 | 41.32 | 4.98 | |
- | 113.51 | 1.89 | 4.32 | 2.05 | -3.69% | -6.70% | -37.61% | 7.73% | -19.31% | 0.00% | 51.25 | 45.74 | 1.71 | |
- | 107.95 | 0.85 | 6.49 | 0.86 | -4.44% | -14.85% | -50.00% | -85.74% | -87.35% | 0.00% | 0.00 | 41.32 | 0.81 | |
- | 117.61 | 81.01 | 348.45 | 95.58 | -0.97% | -7.73% | -53.67% | -57.11% | -32.40% | 0.00% | 8.80 | 41.32 | 1.19 | |
Sotac Pharmaceuticals Ltd | - | 107.20 | - | - | - | - | - | - | - | - | - | - | - | - |
Zenith Drugs Ltd. | - | 69.05 | - | - | - | - | - | - | - | - | - | - | - | - |
Parnax Lab Company background
Founded in: 1982
Managing director: Binoy Baiju Shah
Parnax Lab Limited (Formerly Known as Krishna Deep Trade Investment Ltd ) was incorporated in August, 1982. The Company changed the name from Krishna Deep Trade Investment Ltd to Parnax Lab Limited effective on July 19, 2012. The Company is principally engaged in the business activities of manufacturing and export of Pharmaceutical Formulations. Initially, it was engaged in investment and financing activities.Naxpar Pharma Private Limited is Subsidiary Company of the Holding Company. With over two decades of rich experience behind it, the Naxpar Group is at the helm of innovation in the manufacturing of Pharmaceuticals, Cosmetics, Herbal/Ayurvedic formulations Nutraceuticals (FSSAI) products. The Naxpar Group is headquartered in Mumbai, India. It is as a result of their diligence and perseverance that Naxpars prowess in pharmaceutical manufacturing has seen exponential growth and achievement, significant milestones such as the coveted ISO 9002 status from RWTUV, Germany for following Good Quality Systems in manufacturing and marketing of formulations for domestic and international markets. Naxpar initially began as a singleestablishment indicative of its resounding success and growing client base, the Company now has stateoftheart accredited manufacturing facilities with high speed packing lines in Silvassa, in Dadra Nagar Haveli and Baddi in Himachal Pradesh.Naxpars key strength is manufacturing finished formulations for multinationals in India and abroad and in emerging pharmaceutical markets such as Nigeria, Kazakhstan, Kenya, Mauritius etc. The WHOapproved and EHScompliant Company is now well placed to venture into markets such as South East Asia, CIS, LatAm etc. where it is keen to establish its presence as a leading pharmaceuticals, cosmetics and herbal products manufacturer.
As of 20 Jun, 2025, Parnax Lab share price is ₹100.8. The stock opened at ₹101 and had closed at ₹101 the previous day. During today’s trading session, Parnax Lab share price moved between ₹100.80 and ₹100.95, with an average price for the day of ₹100.00. Over the last 52 weeks, the stock has recorded a low of ₹81.00 and a high of ₹193.50. In terms of performance, Parnax Lab share price has declined by 35.5% over the past six months and has declined by 8.08% over the last year.
Parnax Lab FAQs
How to buy Parnax Lab shares?
You can easily buy Parnax Lab shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
Please be aware that Parnax Lab stock prices are subject to continuous fluctuations due to various factors.
Open Demat Account